We understand that this negative co-IP data indicated that a non-canonical pathway might be operational in PTC harboring HHIP G516R because this novel mutation was able to increase cell proliferation and migration even though HHIP WT has no effect on these tumor cell phenotypes. This evidence concerns the gene HHIP and neoplasm.